Neurotoxicity induced by interleukin-2: Involvement of infiltrating immune cells

Synapse

Volumn 24, Issue 2, 1996, Pages 104-114

  Hanisch, Uwe Karsten ^a,b   Neuhaus, Jochen ^a   Quirion, Rémi ^b   Kettenmann, Helmut ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cytokines; Gliosis; IL 3; Immunoglobulin; Lymphocytes

Indexed keywords

INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOARCHITECTURE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MICROSCOPIC ANATOMY; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; B-LYMPHOCYTES; BRAIN; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; MALE; MICROSCOPY, ELECTRON; NEURONS; PLASMA CELLS; RATS; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTES;

EID: 0029818660     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199610)24:2<104::AID-SYN2>3.0.CO;2-J     Document Type: Article

References (82)

1. Akiyama, H., Tooyama, I., Kondo, H., Ikeda, K., Kimura, H., McGeer, E.G., and McGeer, P.L. (1994) Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res., 635:257-268.
2. Alonso, R., Chaudieu, I., Diorio, J., Krishnamurthy, A., Quirion, R., and Boksa, P. (1993) Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J. Neurochem., 61:1284-1290.
3. Anderson, T.D., and Hayes, T.J. (1989) Toxicity of human recombinant interleukin-2 in rats. Pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement. Lab. Invest., 60:331-346.
4. Anderson, T.D., Hayes, T.J., Powers, G.D., Gately, M.K., Tudor, R., and Rushton, A. (1993) Comparative toxicity and pathology associated with administration of recombinant IL-2 to animals. Int. Rev. Exp. Pathol., 34 Pt A:57-77.
5. Araujo, D.M. (1992) Contrasting effects of specific lymphokines on the survival of hippocampal neurons in culture. Adv. Behav. Biol., 40:113-122.
6. Araujo, D.M., and Cotman, C.W. (1991) Effects of lymphokines on glial and neuronal cells in vitro: A role for lymphokines as modulators of neural-glial interactions. Soc. Neurosci. Abstr., 17:1199.
7. Araujo, D.M., and Lapchak, P.A. (1994) Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: Selective effects on specificinterleukins and interleukin receptors. Neuroscience, 61:745-754.
8. Araujo, D.M., Lapchak, P.A., Collier, B., and Quirion, R. (1989) Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: Interaction with the cholinergic system. Brain Res., 498:257-266.
9. Awatsuji, H., Furukawa, Y., Nakajima, M., Furukawa, S., and Hayashi, K. (1993) Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J. Neurosci. Res., 35:305-311.
10. Banati, R.B., Gehrmann, J., Schubert, P., and Kreutzberg, G.W. (1993) Cytotoxicity of microglia. Glia, 7:111-118.
11. Banks, W.A., and Kastin, A.J. (1992) The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier. Int. J. Immunopharmacol., 14:629-636.
12. Benveniste, E.N., and Merrill, J.E. (1986) Stimulation of oligodendro-glial proliferation and maturation by interleukin-2. Nature, 321:610-613.
13. Bernard, J.T., Ameriso, S., Kempf, R.A., Rosen, P., Mitchell, M.S., and Fisher, M. (1990) Transient focal neurologic deficits complicating interleukin-2 therapy. Neurology, 40:154-155.
14. Brunet, J.M., Berger, F., Gustin, T., Laine, M., and Benabid, A.L. (1993) Characterization of normal brain-reactive antibodies in glioma cyst fluids. J Neuroimmunol., 47:63-72.
15. Caraceni, A., Martini, C., Belli, F., Mascheroni, L., Rivoltini, L., Arienti, F., and Cascinelli, N. (1993) Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. Eur. J. Cancer, 29A:1266-1269.
16. Carrieri, PB., Maiorino, A., Provitera, V., Soscia, E., and Perrella, O. (1992) Cytokines in the pathogenesis of multiple sclerosis. Acta Neurol. (Napoli), 14:333-341.
17. Dalgleish, A.G. (1994) A role of IL-2 in gene therapy. Gene Ther, 1:83-87.
18. Denicoff, K.D., Durkin, T.M., Lotze, M.T., Quinlan, P.E., Davis, C.L., Listwak, S.J., Rosenberg, S.A., and Rubinow, D.R. (1989) The neuroendocrine effects of interleukin-2 treatment. J. Clin. Endocrinol. Metab., 69:402-410.
19. Eddleston, M., and Mucke, L. (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience, 54:15-36.
20. Eitan, S., and Schwartz, M. (1993) A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science, 261:106-108.
21. Eitan, S., Zisling, R., Cohen, A., Belkin, M., Hirschberg, D.L., Lotan, M., and Schwartz, M. (1992) Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration. Proc Natl. Acad. Sci. U.SA, 89:5442-5446.
22. Eizenberg, O., Faber-Elman, A., Lotan, M., and Schwartz, M. (1995) Interleukin-2 transcripts in human and rodent brains: Possible expression by astrocytes. J. Neurochem., 64:1928-1936.
23. Ellison, M.D., and Merchant, R.E. (1991) Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats. J. Neuroimmunol., 33:245-251.
24. Foa, R., Guarini, A., Cignetti, A., Cronin, K., Rosenthal, F., and Gansbacher, B. (1994) Cytokine gene therapy: A new strategy for the management of cancer patients. Nat. Immun., 13:65-75.
25. Funke, I., Prummer, O., Schrezenmeier, H., Hardt, D., Weiss, M., Porzsolt, F, Arnold, R., and Heimpel, H. (1994) Capillary leak syndrome associated with elevated IL-2 serum levels after allogeneic bone marrow transplantation. Ann. Hematol., 68:49-52.
26. Gaspari, A.A. (1994) Autoimmunity as a complication of interleukin 2 immunotherapy. Arch. Dermatol., 130:894-898.
27. Giulian, D. (1993) Reactive glia as rivals in regulating neuronal survival. Glia, 7:102-110.
28. Hanisch, U.K., Seto, D., and Quirion, R. (1993) Modulation of hippocampal acetylcholine release: A potent central action of interleukin-2. J. Neurosci., 13:3368-3374.
29. Hanisch, U.K., Neuhaus, J., Quirion, R., and Kettenmann, H. (1994a) Brain infiltration by autoreactive antibodies induced by central interleukin-2 (IL-2) infusion. Soc. Neurosci. Abstr., 20:954.
30. Hanisch, U.K., Rowe, W., Sharma, S., Meaney, M.J., and Quirion, R. (1994b) Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology, 135: 2465-2472.
31. Heath, W.R., Allison, J., Hoffmann, M.W., Schonrich, G., Hammerling, G., Arnold, B., and Miller, J.F. (1992) Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature, 359:547-549.
32. Hopkins, S.J., and Rothwell, N.J. (1995) Cytokines and the nervous system I: Expression and recognition. Trends Neurosci., 18:83-88.
33. Jaradeh, S., Schuelke, G., and Goldman, R.S. (1993) Effects of in-situ interleukin-2 on rat peripheral nerve. Soc. Neurosci. Abstr, 19:504.
34. Kaneko, K., Seki, K., Ishida, K., Uchihara, T., Kanda, T., Inuzuka, T., and Miyatake, T. (1993) Circulating autoantibody to mature neurons and astrocytes of humans and some mammals present in a demented patient with autoimmune disorder. Eur. Neurol., 33:450-453.
35. Kroemer, G., Andreu, J.L., Gonzalo, J.A., Gutierrez Ramos, J.C., and Martinez, C. (1991) Interleukin-2, autotolerance, and autoimmunity. Adv. Immunol., 50:147-235.
36. Kuziel, W.A., and Greene, W.C. (1991) Interleukin-2. In: The Cytokine Handbook, Vol. 1. A. Thomsen, ed. Academic Press, London, pp. 83-102.
37. Lapchak, P.A. (1992) A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport, 3:165-168.
38. Lapchak, P.A., Araujo, D.M., Quirion, R., and Beaudet, A. (1991) Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience, 44:173-184.
39. Lissoni, P., Rovelli, F., Tancini, G., Tisi, E., Rivolta, M.R., Ardizzoia, A., and Brivio, F. (1992) Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancer. J. Biol. Regul. Homeost. Agents, 6:113-115.
40. Luber-Narod, J. and Rogers, J. (1988) Immune system associated antigens expressed by cells of the human central nervous system. Neurosci. Lett., 94:17-22.
41. Maas, R.A., Dullens, H.F., and Den Otter, W. (1993) Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review. Cancer Immunol. Immunother., 36:141-148.
42. McCann, S.M., Karanth, S., Kamat, A., Les Dees, W., Lyson, K., Gimeno, M., and Rettori, V. (1994) Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation, 1:2-13.
43. Meyers, C.A., and Yung, W.K. (1993) Delayed neurotoxicity of intraventricular interleukin-2: A case report. J. Neurooncol., 15:265-267.
44. Morganti-Kossmann, M.C., Kossmann, T., and Wahl, S.M. (1992) Cytokines and neuropathology. Trends Pharmacol. Sci., 13:286-291.
45. Mucke, L., and Eddleston, M. (1993) Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J., 7:1226-1232.
46. Nieto Sampedro, M., and Chandy, K.G. (1987) Interleukin-2-like activity in injured rat brain. Neurochem. Res., 12:723-727.
47. Nieto Sampedro, M., and Mora, F. (1994) Active microglia, sick astroglia and Alzheimer type dementias. Neuroreport, 5:375-380.
48. Nistico, G. (1993) Communications among central nervous system, neuroendocrine and immune systems: Interleukin-2. Prog. Neurobiol., 40:463-475.
49. Nistico, G., and De Sarro, G. (1991a) Is interleukin 2 a neuromodulator in the brain?. Trends Neurosci., 14:146-150.
50. Nistico, G., and De Sarro, G. (1991b) Behavioral and electrocortical spectrum power effects after microinfusion of lymphokines in several areas of the rat brain. Ann. N.Y. Acad. Sci., 621:119-134.
51. Opdenakker, G., and Van Damme, J. (1994) Cytokine-regulated proteases in autoimmune diseases. Immunol. Today, 15:103-107.
52. Otero, G.C., and Merrill, J.E. (1994) Cytokine receptors on glial cells. Glia, 11:117-128.
53. Otero, G.C., and Merrill, J.E. (1995) Molecular cloning of IL-2α, IL-2β, and IL-2Rγ cDNAs from a human oligodendroglioma cell line: Presence of IL-2R mRNAs in the human central nervous system. Glia, 14:295-302.
54. Petitto, J.M., and Huang, Z. (1994) Molecular cloning of a partial cDNA of the interleukin-2 receptor-β in normal mouse brain: In situ localization in the hippocampus and expression by neuroblastoma cells. Brain Res., 650:140-145.
55. Plata Salaman, C.R. (1991) Immunoregulators in the nervous system. Neurosci. Biobehav. Rev., 15:185-215.
56. Plata Salaman, C.R., and ffrench Mullen, J.M. (1993) Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons. Neuroreport, 4:579-581.
57. Raber, J., and Bloom, F.E. (1994) IL-2 induces vasopressin release from the hypothalamus and the amygdala: Role of nitric oxide-mediated signaling. J. Neurosci., 14:6187-6195.
58. Ram, Z., Walbridge, S., Heiss, J.D., Culver, K.W., Blaese, R.M., and Oldfield, E.H. (1994) In vivo transfer of the human interleukin-2 gene: Negative tumoricidal results in experimental brain tumors. J. Neurosurg., 80:535-540.
59. Rothwell, N.J., and Hopkins, S.J. (1995) Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci., 18:130-136.
60. Rothwell, N.J., and Relton, J.K. (1993) Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev., 17:217-227.
61. Rubin, J.T. (1993) Interleukin-2: Its biology and clinical application in patients with cancer. Cancer Invest., 11:460-472.
62. Saneto, R.P., Chiapelli, F., and De Vellis, J. (1987) Interleukin-2 inhibition of oligodendrocyte progenitor proliferation depends on expression of the Tac receptor. J. Neurosci. Res., 18:147-154.
63. Sarder, M., Saito, H., and Abe, K. (1993) Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain. Brain Res., 625:347-350.
64. Saris, S.C., Patronas, N.J., Rosenberg, S.A., Alexander, J.T., Frank, J., Schwartzentruber, D.J., Rubin, J.T., Barba, D., and Oldfield, E.H. (1989) The effect of intravenous interleukin-2 on brain water content. J. Neurosurg., 71:169-174.
65. Sawada, M., Suzumura, A., and Marunouchi, T. (1995) Induction of interleukin-2 receptor in mouse microglia. J. Neurochem., 64:1973-1979.
66. Schattner, A. (1994) Lymphokines in autoimmunity - a critical review. Clin. Immunol. Immunopathol., 70:177-189.
67. Schobitz, B., Holsboer, F., and de Klot, E.R. (1994) Cytokines in healthy and diseased brain. NIPS, 9:138-142.
68. Selmaj, K.W., and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol., 23:339-346.
69. Shimojo, M., Imai, Y., Nakajima, K., Mizushima, S., Uemura, A., and Kohsaka, S. (1993) Interleukin-2 enhances the viability of primary cultured rat neocortical neurons. Neurosci. Lett., 151:170-173.
70. Sone, S., and Ogura, T. (1994) Local interleukin-2 therapy for cancer, and its effector induction mechanisms. Oncology, 51:170-176.
71. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. (1994) Macrophages and angiogenesis. J. Leukoc. Biol., 55:410-422.
72. Tancredi, V., Zona, C., Velotti, F., Eusebi, F., and Santoni, A. (1990) Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res., 525:149-151.
73. Taniguchi, T., and Minami, Y. (1993) The IL-2/IL-2 receptor system: A current overview. Cell, 73:5-8.
74. Tartour, E., Mathiot, C., and Fridman, W.H. (1992) Current status of interleukin-2 therapy in cancer. Biomed. Pharmacother., 46:473-484.
75. Vedeler, C., Ulvestad, E., Grundt, I., Conti, G., Nyland, H., Matre, R., and Pleasure, D. (1994) Fc receptor for IgG (FcR) on rat microglia. J. Neuroimmunol., 49:19-24.
76. Vial, T., and Descotes, J. (1992) Clinical toxicity of interleukin-2. Drug Saf., 7:417-433.
77. Villemain, F., Owens, T., Renno, T., and Beaudet, A. (1991) Localization of mRNA for interleukin-2 (IL-2) in mouse brain by in situ hybridization. Soc. Neurosci. Abstr, 17:1199.
78. Waguespack, P.J., Banks, W.A., and Kastin, A.J. (1994) Interleukin-2 does not cross the blood-brain barrier by a saturable transport system. Brain Res. Bull., 34:103-109.
79. Waldmann, T.A. (1993) The IL-2/IL-2 receptor system: A target for rational immune intervention. Immunol. Today, 14:264-270.
80. Wang, F.Z., Yao, H., and Ding, A.S. (1994) Effects of interleukin-1 and interleukin-2 on rat hippocampal neurons in culture. Soc. Neurosci. Abstr., 20:1687.
81. Wells, M.R., Racis, S.P., Jr., and Vaidya, U. (1992) Changes in plasma cytokines associated with peripheral nerve injury. J. Neuroimmunol., 39:261-268.
82. Whittington, R., and Faulds, D. (1993) Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs, 46:446-514.